1,909 Shares in Cardinal Health, Inc. $CAH Bought by Brookwood Investment Group LLC

Brookwood Investment Group LLC acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 1,909 shares of the company’s stock, valued at approximately $321,000.

Several other hedge funds and other institutional investors have also modified their holdings of CAH. Wellington Management Group LLP raised its holdings in shares of Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after acquiring an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after buying an additional 1,193,983 shares in the last quarter. Zurich Insurance Group Ltd FI raised its holdings in Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after buying an additional 927,950 shares in the last quarter. Nuveen LLC bought a new position in Cardinal Health during the first quarter valued at about $106,065,000. Finally, T. Rowe Price Investment Management Inc. bought a new position in Cardinal Health during the first quarter valued at about $104,951,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Down 0.4%

Shares of CAH opened at $163.13 on Wednesday. Cardinal Health, Inc. has a 12-month low of $106.98 and a 12-month high of $168.44. The firm has a market capitalization of $38.76 billion, a price-to-earnings ratio of 25.29, a P/E/G ratio of 1.39 and a beta of 0.71. The stock’s 50-day moving average price is $153.32 and its 200 day moving average price is $153.50.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. During the same period in the previous year, the company posted $1.84 earnings per share. The company’s quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date was Wednesday, October 1st. Cardinal Health’s payout ratio is currently 31.63%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on CAH shares. Argus set a $189.00 target price on Cardinal Health in a report on Friday, August 22nd. Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Leerink Partners raised their target price on Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a report on Monday, October 6th. Wells Fargo & Company restated an “overweight” rating and set a $185.00 target price (up from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Finally, Robert W. Baird lifted their price objective on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $166.00.

Insider Activity

In related news, CEO Stephen M. Mason sold 41,575 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer directly owned 26,085 shares in the company, valued at $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Jason M. Hollar sold 107,705 shares of the business’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total value of $16,037,274.50. Following the transaction, the chief executive officer owned 235,901 shares in the company, valued at $35,125,658.90. This represents a 31.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 271,676 shares of company stock valued at $40,489,525. Corporate insiders own 0.12% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.